openPR Logo
Press release

Inflammatory Bowel Disease Market Growth and Development Analysis including Top Key Players: Pfizer Inc., Shire Plc., Janssen Biotech, Inc., AbbVie Inc., Allergan plc., Novartis AG, UCB Inc.

11-05-2018 10:26 AM CET | Health & Medicine

Press release from: Polaris Market Research & Consulting

Inflammatory Bowel Disease Market

Inflammatory Bowel Disease Market

Inflammatory Bowel Disease is the type of gastrointestinal inflammatory disease. This disease causes long term chronic and severe inflammation in the intestinal tract. Similarly, it can be termed as an inflammatory condition to the colon and small intestine. Inflammatory bowel disease (IBD) on the basis of indication is segmented into Crohn’s disease, and ulcerative colitis. Crohn’s disease not only affects the small intestine but also has the ability to affect the mouth, stomach, the anus, and oesophagus. Whereas, ulcerative colitis affects the rectum and the colon. The number of patients suffering from IBD is on rise due to changing lifestyle globally. According to CDC, there are more than 70,000 new cases of IBD every year in North America.

Request Sample Pages for more Professional and Technical insights @
http://bit.ly/2RyAkJX

Inflammatory Bowel Disease Market size to gain traction owning to the factors such as increasing population suffering with IBD that is majorly influenced by the changing lifestyle preferences across the globe.
In the recent years, there are various research studies that have been focusing on the causes of inflammatory bowel disease. The major causes of IBD includes the genetic mutations that are caused in NOD2/CARD15 gene, and virus or bacteria. In general, inflammatory bowel disease (IBD) is majorly caused by immune malfunctioning, in which the immune system attacks the healthy cells in digestive tract. The factors like age, ethnicity, cigarette smoking, intake of non-steroidal anti-inflammatory medications, and family history support the growth of IBD. The common symptoms observed in an individual suffering from IBD are persistent diarrhoea, cramps in abdomen, fever, and occasional rectal bleeding.

Changing eating habits and increasing preference for sedentary life style are main factors which are responsible for the growth of Inflammatory Bowel Disease Market.

For 'Queries' related to this research report, Make an Enquiry @
http://bit.ly/2RycT3u

Geographically, the Inflammatory Bowel Disease Market to be segmented as North America, Europe, Asia Pacific, Latin America & Middle East and Africa. North America region is expected to dominate this market over the forecast period. North America holds major share owning to the rising number of patients suffering from ulcerative colitis and Crohn’s disease, and changed diet preferences in this region. Moreover, well established healthcare infrastructure by the governments in North America to boom the inflammatory bowel disease market in the near future.

However, Asia Pacific to grow at a faster pace in the forecast period. Higher population in this region, and increased preference for sedentary lifestyle in the developing countries are the major factors that anticipated to govern the growth in Asia Pacific market during upcoming years.

Key players in the Inflammatory Bowel Disease Market are:
• Pfizer Inc.
• Shire Plc.
• Janssen Biotech, Inc.
• AbbVie Inc.
• Allergan plc.
• Novartis AG
• UCB Inc.
• Biogen Inc.
• Valent Pharmaceuticals International, Inc.
• Takeda Pharmaceuticals Company Limited.

Table of Content of Inflammatory Bowel Disease Market:

Chapter 1. Overview and Scope
Chapter 2. Market Summary
Chapter 3 Inflammatory Bowel Disease Market Size and Forecast
Chapter 4. Dynamics and Segmentation
Chapter 5. Detailed Insight on Key Company
Chapter 6. Research Methodology and Reference
Chapter 7. Competitive Landscape
TOC Continued…...!!!

About Us:
Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for our clientele spread across different enterprises. We at Polaris are obliged to serve our diverse customer base present across the industries of healthcare, technology, semi-conductors and chemicals among various other industries present around the world. We strive to provide our customers with updated information on innovative technologies, high growth markets, emerging business environments and latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities. Adept with a highly competent, experienced and extremely qualified team of experts comprising SMEs, analysts and consultants, we at Polaris endeavor to deliver value-added business solutions to our customers.

Contact Us:
Mr. Neel
Corporate Sales, USA
Polaris Market Research and Consulting
Phone: 1-646-568-9980
Email: sales@polarismarketresearch.com
Web: www.polarismarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Inflammatory Bowel Disease Market Growth and Development Analysis including Top Key Players: Pfizer Inc., Shire Plc., Janssen Biotech, Inc., AbbVie Inc., Allergan plc., Novartis AG, UCB Inc. here

News-ID: 1351499 • Views: 110

More Releases from Polaris Market Research & Consulting

What's driving the Blockchain Technology Market Trends? Microsoft Corporation, I …
The worldwide market size for blockchain technology is estimated to grow at a CAGR of 41.6% between 2018 and 2026 and is anticipated to reach USD 16.82 billion by 2026. According to a new study published by Polaris Market Research. Also termed as Distributed Ledger Technology (DLT), blockchain enables secure transaction over a distributed network. Since the transactions are taken place usually over the network, it is difficult to reverse
What's driving the Precision Farming Market Trends? Ag Leader Technology, AgJunc …
The global precision farming/agriculture market was valued at 3,833 million in 2017 and is anticipated to reach over USD 13,016 million by 2026 with grow at a CAGR of more than 14.7% during the forecast period According to a new study published by Polaris Market Research. In 2017, the yield monitoring application dominated the global market, in terms of revenue. North America is expected to be the leading contributor to
What are the different trends in Electric Vehicles (EV) Market to boost its grow …
Polaris Market Research has new report published the addition of the “The global Electric Vehicles Market Worth $912 Billion By 2026 | CAGR: 38.4%”, the report classifies the global Electric Vehicles market in a precise manner to offer unearth valuable, accurate and reliable data insights that help organizations to meet their business objectives and enable growth Get PDF Sample of “Electric Vehicles Market”: https://www.polarismarketresearch.com/industry-analysis/electric-vehicles-ev-market/request-for-sample The global electric vehicles market is anticipated to
What are the different trends in Third Party Logistics Market to boost its growt …
Polaris Market Research has new report published the addition of the “The global third-party logistics market is anticipated to reach USD 1,337.91 billion by 2026”, the report classifies the global third-party logistics market in a precise manner to offer unearth valuable, accurate and reliable data insights that help organizations to meet their business objectives and enable growth according to a new report The report “Third Party Logistics (3PL) Market Share, Size,

All 5 Releases


More Releases for Inflammatory

Digital Landscape: Inflammatory Bowel Disease Market
The Digital Landscape Inflammatory Bowel Disease market report analyzes digital activities undertaken by pharma in support of disease-modifying therapies for mild-to-moderate, and moderate-to-severe Crohn’s disease and ulcerative colitis (UC). Key Highlights - US Patients: AbbVie offers the strongest support for IBD patients in the US, particularly branded, unbranded and mobile app. Janssen was the most active competitor in the branded and social media spaces in 2017. Branded activity also seen from pipeline
Rare Inflammatory Disease Treatment Market CAGR to Grow at 4.4%
With mounting instances of genetic diseases, demand for therapeutic measures have witnessed a hike, as no effective procedures exist that provide effective treatment of genetic or rare inflammatory diseases. Chromosomal changes primarily influence prevalence of these diseases. In a bid to curtail the disease prevalence, several pharmaceutical industries have been taking efforts to make advancements in relevant drugs as well as therapeutic methods. For example, new treatment options are
Anti-Inflammatory Peptides Market to Develop Rapidly by 2015 – 2023
Anti Inflammatory Peptides Market: Overview Anti-inflammatory peptides also known as antiflammins inhibit inflammation of a mammal’s skin, lacerations of the musculature, mucous membranes, or injury into the air spaces of the lungs. Anti-inflammatory peptides act by hindering synthesis of platelet-activating factor, neutrophil aggregation and chemotaxis, and intradermal inflammatory reactions. Anti-Inflammatory peptides are used to treat diseases such as psoriasis, multiple sclerosis, inflammatory bowel disease and other autoimmune diseases. Download PDF Brochure of
Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) - Pipeline Review, H2 2 …
ReportsWorldwide has announced the addition of a new report title Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) - Pipeline Review, H2 2017 to its growing collection of premium market research reports. Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) - Pipeline Review, H2 2017, provides an overview of the Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) (Central Nervous System) pipeline landscape. Chronic inflammatory demyelinating polyneuropathy (CIDP) also called as
Anti-Inflammatory Therapeutics Market - Positive long-term growth outlook 2019
Also known as non-steroidal anti- inflammatory drugs, anti-inflammatory therapeutics help in easing acute and mild chronic pain. Be it migraines and headaches, rheumatic arthritis, sprains, or even menstrual pain, anti- inflammatory therapeutics can provide faster relief as compared with other drugs. They are capable of lowering the levels of prostaglandins, the chemicals responsible for inflammation, reducing pain and swelling. Aspirin, acelofenac, celecoxib, etoricoxib, acemetacin, etodolac, ibuprofen, Meloxicam, tenoxicam, dexketoprofen, fenoprofen, sulindac,
Chronic Inflammatory Demyelinating Polyneuropathy (CIPD) Treatment Market
Chronic inflammatory demyelinating polyneuropathy (CIPD) is an autoimmune disorder of the peripheral nervous system characterized by the weakness and impaired sensory function in the arms and legs. This disorder is caused by damage to the myelin sheath, a fatty covering that wraps and protects nerve fibers. The nerves stimulate muscle contraction and transmit sensory information to the brain through electrical impulses. Myelin acts as an insulation and allows efficient flow